Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Discovery of Endogenous Protein That Prevents Coronavirus from Fusing with Host Cells Could Help Stop COVID-19

By HospiMedica International staff writers
Posted on 03 Aug 2020
An international team of researchers has demonstrated that a protein produced by the human immune system can strongly inhibit coronaviruses, including SARS-CoV-2, thus raising hopes of new therapeutic approaches for the treatment of COVID-19.

An international team comprising researchers from the University of Bern (Bern, Switzerland), the Swiss Federal Office for Food Safety and Animal Health (Köniz, Switzerland), and the Ruhr-University Bochum (RUB Bochum, Germany) successfully showed that the so-called LY6E-Protein prevents coronaviruses from causing an infection.

The LY6E protein plays a role in various diseases. More...
The researchers discovered that the protein enhances the infectivity of influenza viruses. In contrast, coronaviruses are inhibited by LY6E. In their effort to search for genes that prevent coronavirus infections, the researchers attempted to identify proteins in the human body that inhibit the spread of coronaviruses by carrying out genetic screening of several hundred so-called interferon-stimulated genes (ISGs). Among other things, ISGs produce antiviral proteins and protect against pathogens. The protein LY6E showed the strongest inhibitory effect on all coronaviruses tested, including the pathogens causing SARS and MERS as well as SARS-CoV-2 which causes COVID-19. Tests with different cell cultures showed that LY6E affects the ability of the virus to fuse with the host cells. If the virus is unable to fuse with these cells, then it cannot cause infection.

"This finding might lead to the development of new therapeutic approaches against coronaviruses," said Professor Stephanie Pfänder from the Department for Molecular and Medical Virology at RUB, co-lead author of the study.

"We wanted to find out which factors prevent corona viruses from spreading from animals to humans," said corresponding author Prof. Volker Thiel from the IVI. "Now we have succeeded in finding the needle in the haystack, so to speak. Our study provides new insights into how important these antiviral genes are for the control of viral infection and for an adequate immune response against the virus."

Related Links:
University of Bern
Swiss Federal Office for Food Safety and Animal Health
Ruhr-University Bochum



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.